Equities Analysts Set Expectations for Henry Schein, Inc.’s Q2 2025 Earnings (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Zacks Research boosted their Q2 2025 earnings per share (EPS) estimates for Henry Schein in a research report issued to clients and investors on Tuesday, April 16th. Zacks Research analyst U. Biswas now anticipates that the company will post earnings per share of $1.27 for the quarter, up from their prior estimate of $1.26. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The firm had revenue of $3.02 billion during the quarter, compared to analyst estimates of $3 billion. During the same quarter in the previous year, the business posted $1.21 EPS. Henry Schein’s revenue was down 10.5% compared to the same quarter last year.

Other research analysts have also issued reports about the company. Jefferies Financial Group raised their price objective on Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. Barrington Research lifted their target price on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 28th. Evercore ISI lifted their target price on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research report on Wednesday, February 28th. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. Finally, Piper Sandler lifted their target price on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $81.09.

Henry Schein Trading Down 0.3 %

NASDAQ:HSIC opened at $69.97 on Thursday. The business’s 50-day moving average is $74.43 and its two-hundred day moving average is $72.48. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. Henry Schein has a 12 month low of $60.01 and a 12 month high of $85.39. The firm has a market capitalization of $8.99 billion, a PE ratio of 22.21, a price-to-earnings-growth ratio of 1.76 and a beta of 0.87.

Insider Activity at Henry Schein

In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Henry Schein

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Baystate Wealth Management LLC raised its holdings in Henry Schein by 2,500.0% during the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock worth $39,000 after purchasing an additional 500 shares in the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in Henry Schein during the fourth quarter worth approximately $39,000. Neo Ivy Capital Management bought a new stake in Henry Schein during the third quarter worth approximately $46,000. Covestor Ltd raised its holdings in Henry Schein by 88.4% during the first quarter. Covestor Ltd now owns 861 shares of the company’s stock worth $75,000 after purchasing an additional 404 shares in the last quarter. Finally, Harbour Investments Inc. raised its holdings in Henry Schein by 27,725.0% during the fourth quarter. Harbour Investments Inc. now owns 1,113 shares of the company’s stock worth $84,000 after purchasing an additional 1,109 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.